Pharmaceutical company AstraZeneca will invest around 1.4 billion kronor (200 million dollar), in a new factory in China. The factory will be located in Taizhou, in the Jiangsu province. Construction of the site is scheduled to be completed at the end of 2013.
It will be AstraZeneca's largest ever investment in an individual production facility, according to the press statement.
